MyFinsight
Home
About
Contact
janx: the income statement
Download
Download image
Comprehensive loss
-$23,498K
(-26.25%↓ Y/Y)
Unrealized gain on
available-for-sale securities, net
$815K
(-91.37%↓ Y/Y)
Interest income
$10,938K
(40.54%↑ Y/Y)
Net loss
-$24,313K
(13.35%↑ Y/Y)
Total other income
$10,938K
(40.54%↑ Y/Y)
Loss from operations
-$35,251K
(1.65%↑ Y/Y)
Collaboration revenue
$10,000K
(2177.90%↑ Y/Y)
Total operating
expenses
$45,251K
(24.72%↑ Y/Y)
General and
administrative
$10,622K
(-39.88%↓ Y/Y)
Research and development
$34,629K
(86.04%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Janux Therapeutics, Inc. (JANX)
Janux Therapeutics, Inc. (JANX)